OMDA
Income statement / Annual
Last year (2024), Omada Health's total revenue was $169.80 M,
an increase of 38.29% from the previous year.
In 2024, Omada Health's net income was -$47.14 M.
See Omada Health,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
| Operating Revenue |
$169.80 M |
$122.78 M |
$89.19 M |
| Cost of Revenue |
$66.92 M
|
$52.81 M
|
$46.39 M
|
| Gross Profit |
$102.88 M
|
$69.97 M
|
$42.79 M
|
| Gross Profit Ratio |
0.61
|
0.57
|
0.48
|
| Research and Development Expenses |
$35.92 M
|
$33.74 M
|
$26.17 M
|
| General & Administrative Expenses |
$42.56 M
|
$35.98 M
|
$30.49 M
|
| Selling & Marketing Expenses |
$68.05 M
|
$66.25 M
|
$58.48 M
|
| Selling, General & Administrative Expenses |
$110.61 M
|
$102.23 M
|
$88.97 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$146.53 M
|
$135.97 M
|
$115.14 M
|
| Cost And Expenses |
$213.45 M
|
$188.78 M
|
$161.54 M
|
| Interest Income |
$805.00 K
|
$5.78 M
|
$2.20 M
|
| Interest Expense |
$4.51 M
|
$4.71 M
|
$4.20 M
|
| Depreciation & Amortization |
$4.80 M
|
$4.45 M
|
$4.33 M
|
| EBITDA |
-$37.83 M |
-$58.36 M |
-$63.99 M |
| EBITDA Ratio |
-0.22
|
-0.48
|
-0.72
|
| Operating Income Ratio |
-0.26
|
-0.54
|
-0.81
|
| Total Other Income/Expenses Net |
-$3.48 M
|
-$1.51 M
|
-$168.00 K
|
| Income Before Tax |
-$47.14 M
|
-$67.51 M
|
-$72.52 M
|
| Income Before Tax Ratio |
-0.28
|
-0.55
|
-0.81
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$47.14 M
|
-$67.51 M
|
-$72.52 M
|
| Net Income Ratio |
-0.28
|
-0.55
|
-0.81
|
| EPS |
-0.85 |
-1.21 |
-1.3 |
| EPS Diluted |
-0.85 |
-1.21 |
-1.3 |
| Weighted Average Shares Out |
$55.74 M
|
$55.74 M
|
$55.74 M
|
| Weighted Average Shares Out Diluted |
$55.74 M
|
$55.74 M
|
$55.74 M
|
| Link |
|
|
|
